Prescriber Profiling

  1. Alexander C. Tsai, MD, PhD
  1. From the University of Washington School of Medicine, Seattle, WA 98104-2499.

    TO THE EDITOR:

    Given that fewer than 1% of American Medical Association (AMA) members have participated in the Prescribing Data Restriction Program (PDRP), only 25% of surveyed members are aware of the program's existence, and 66% disapprove of the sale of physician-specific prescribing data to drug companies, Grande's concern that “the AMA opt-out program is not an effective way to address the concerns of physicians and their patients” (1) is a tactful understatement.

    A thorough literature review at the PDRP's inception would have …

    « Previous | Next Article »Table of Contents